FDA Raises Concerns on Safety, Tolerability of Potential Myeloma Therapy Selinexor
The U.S. Food and Drug Administration has raised concerns…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Once-weekly Kyprolis Safe, Effective for Untreated Multiple Myeloma Patients, Study Finds
Treatment with Kyprolis (carfilzomib) once a week is as safe…
Gamida, Editas Partner to Create Genetically Engineered NAM-NK Cells for Treating Blood, Solid Cancers
Gamida Cell and Editas Medicine have entered a…
It’s Off to the Races for eRace Cancer’s 78-year-old Founder and Multiple Myeloma Survivor
In 2003, Don Wright received a daunting diagnosis of …
Ninlaro Maintenance Delays Disease Progression, Death in Myeloma Patients, Phase 3 Trial Shows
Multiple myeloma patients who receive Ninlaro (ixazomib)…
International Myeloma Foundation Gears Up for March, Myeloma Action Month
To raise awareness of multiple myeloma and efforts to…
